Piper Jaffray Remains Sidelined on Teva Pharma (TEVA) Following 1Q - PT to $58

Adamis Pharmaceuticals (ADMP) Enters Epinephrine PFS Licensing Agreement with Allergan (AGN) Unit

May 10, 2016 6:46 AM EDT

Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) has entered into an exclusive licensing agreement with Allergan plcs (NYSE: AGN) wholly owned subsidiary, Watson Laboratories, Inc. (Watson), to commercialize Adamis Epinephrine Pre-filled Syringe (PFS) product candidate for the emergency treatment of anaphylaxis.

Under the terms of the agreement, Watson will obtain commercial rights for the U.S. in exchange for an upfront... More

Teva Pharma (TEVA) Attractive, Well Managed Business; Price Cut to $75 - Mizuho

May 10, 2016 6:45 AM EDT

Mizuho analyst, Irina Koffler maintained her Buy rating after Teva Pharma (NYSE: TEVA) effectively defended its generics business and eased concerns about the AGN deal closure. A bottom line beat also helped the stock. We think this is a well-managed business and valuation... More

Pre-Open Stock Movers 05/09: (KKD) (SSYS) (WATT) Higher; (UNIS) (LC) (SPHS) Lower (more...)

May 9, 2016 9:35 AM EDT

Unilife Corporation (NASDAQ: UNIS) 38.9% LOWER; announced that it is postponing its earnings conference call, originally scheduled to be held at 8:00 a.m. EDT on Monday, May 9, 2016 (Monday, May 9, 2016 at 10:00 p.m. AEST) due to the discovery by the Company's current management team of violations of Company policies and procedures and possible violations of law and regulation by the Company's former Chief Executive Officer and by the former Chairman of the Company's Board of Directors who resigned in 2015.

Krispy Kreme Doughnuts, Inc. (NYSE:... More

Higher health stocks and falling oil leave S&P 500 flat

May 9, 2016 9:07 AM EDT

By Noel Randewich

(Reuters) - Wall Street ended mixed on Monday after a rally in Allergan Plc and other healthcare companies offset a decline in energy shares.

Five of 10 S&P sectors ended higher, led by the health sector's 1.13 percent increase, while energy and materials sectors both tumbled 1.25 percent.

Allergan (NYSE: AGN) surged 5.98 percent. Teva Pharmaceutical Industries Ltd (NYSE: TEVA) (NYSE: TEVA) said it still expected its $40.5 billion acquisition of Allergan's generic drug business to close in... More

Teva Pharma (TEVA) Tops Q1 EPS by 3c

May 9, 2016 7:01 AM EDT

Teva Pharma (NYSE: TEVA) reported Q1 EPS of $1.20, $0.03 better than the analyst estimate of $1.17. Revenue for the quarter came in at $4.81 billion versus the consensus estimate of $4.78 billion.

We start 2016 with solid performance across the business, strong financial results and the achievement of several key... More

Trading Radar for 5/9: Tyson Foods (TSN), Stratasys (SSYS), Wayfair (W), MBIA (MBI) Report

May 6, 2016 2:45 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

AES Corp (Nasdaq: AES) - consensus EPS $0.20
Alaska Communications Systems (Nasdaq: ALSK) - consensus EPS $0.00
Altisource Residential (Nasdaq: RESI) - consensus loss $0.06
Apricus Biosciences (Nasdaq: APRI) - consensus loss $0.09
Armstrong World (Nasdaq: AWI) - consensus EPS $0.41
BIND Therapeutics (Nasdaq: BIND) - consensus loss... More